Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CV Sciences Inc CVSI

CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business to business-to-consumer. It operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based therapeutics. It develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under brands: +PlusCBD and Cultured Foods in the healthcare market sector: nutraceutical, beauty care, specialty foods, and pet products. +PlusCBD branded products are sold at select retail locations throughout the United States. Cultured Foods brand provides a variety of plant-based food products and caters to individuals seeking vegan, gluten-free, or flexitarian options for a culinary experience. It manufactures encapsulated softgels and tinctures for the supplement and nutrition industry.


OTCQB:CVSI - Post by User

Bullboard Posts
Post by Bigchunguson Jun 10, 2019 10:59pm
460 Views
Post# 29814006

DionyMed Brands Inc. Announces First Quarter 2019 n kills it

DionyMed Brands Inc. Announces First Quarter 2019 n kills it14.2mm USD or 19mm CAD Q1 revenue. Approaching an annual run rate of 80mm CAD and a mere 100mm cap. This e-commerce platform distributes to over 900 retailers and makes thousands of direct to consumer deliveries daily and is expanding rapidly. This puts DYME in approx 13th on the U.S. overall cannabis revenue generator and exceeds many established Canadian producers sales, including Aphria and other noteworthy LPs. Who wouldn’t want cannabis delivered straight to your door? This company is largely under the radar and worth noting, a near 52w low. Super low float, so this could easily hit the analysts target of $6.00 from its current $2.08 in short order. Anticipated 2019 revenue of 162 million CAD

Order here:  https://www.orderchill.com/

https://www.newcannabisventures.com/cannabis-company-revenue-ranking/

Bullboard Posts